FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 322:717-722 March 15, 1990 Number 11 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Infection is a frequent complication in patients undergoing hemodialysis for end-stage renal disease and is the primary cause of mortality among such patients. Macrophages are important in host defense against infection largely because their Fc gamma receptors recognize antibody-coated bacteria. We therefore studied macrophage Fc gamma-receptor function in vivo and in vitro in 56 patients with end-stage renal disease who were on hemodialysis and in 20 healthy volunteers. The clearance of IgG-coated (sensitized) autologous red cells was decreased in 53 patients. The inhibition of clearance in the 56 patients was 52 +/- 3 percent at 1 hour, 41 +/- 5 percent at 1 1/2 hours, and 29 +/- 5 percent at 2 hours (P less than 0.001). The clearance of unsensitized erythrocytes and heat-altered autologous erythrocytes was normal. The impairment of clearance was not correlated with age, sex, nutritional status, HLA haplotype, or the presence of circulating immune complexes. The recognition of these IgG-sensitized red cells in vitro by Fc gamma RI (an Fc gamma-receptor protein that binds monomeric IgG) on blood monocytes from the patients was also significantly decreased (P less than 0.001) but was partially improved by hemodialysis. Nine patients had severe infections during a two-year follow-up period. The clearance of IgG-coated cells in these patients (half-time, 12.9 +/- 1.7 hours) was significantly impaired, as compared with that in the 47 patients without severe infections (half-time, 4.4 +/- 1.8 hours; P less than 0.001). We conclude that macrophage Fc gamma-receptor function is impaired in patients with end-stage renal disease who are undergoing hemodialysis, and that this impairment probably contributes to the observed immunodepression and high prevalence of infection among such patients.

Source Information

Department of Medicine, Hospital of the University of Cadiz, Spain.

This article has been cited by other articles:

• Sherry, B., Dai, W. W., Lesser, M. L., Trachtman, H. (2008). Dysregulated Chemokine Receptor Expression and Chemokine-Mediated Cell Trafficking in Pediatric Patients with ESRD. CJASN 3: 397-406 [Abstract] [Full Text]  
• Canetti, C., Hu, B., Curtis, J. L., Peters-Golden, M. (2003). Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood 102: 1877-1883 [Abstract] [Full Text]  
• Gomez, F., Ruiz, P., Lopez, R., Rivera, C. (2002). Treatment with Megestrol Acetate Improves Human Immunodeficiency Virus-Associated Immune Thrombocytopenia. CVI 9: 583-587 [Abstract] [Full Text]  
• Espinosa, M., Martin-Malo, A., de Lara, M. A. A., Aljama, P. (2001). Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 16: 1669-1674 [Abstract] [Full Text]  
• Gomez, F., Ruiz, P., Bernal, J. A., Escobar, M., Garcia-Egido, A., Lopez-Saez, J. J. B. (2001). Enhancement of Splenic-Macrophage Fc{gamma} Receptor Expression by Treatment with Estrogens. CVI 8: 806-810 [Abstract] [Full Text]  
• BALAKRISHNAN, V. S., SCHMID, C. H., JABER, B. L., NATOV, S. N., KING, A. J., PEREIRA, B. J. G. (2000). Interleukin-1 Receptor Antagonist Synthesis by Peripheral Blood Mononuclear Cells: A Novel Predictor of Morbidity among Hemodialysis Patients. J. Am. Soc. Nephrol. 11: 2114-2121 [Abstract] [Full Text]  
• Gomez, F., Ruiz, P., Lopez, R., Rivera, C., Romero, S., Bernal, J. A. (2000). Effects of Androgen Treatment on Expression of Macrophage Fcgamma Receptors. CVI 7: 682-686 [Abstract] [Full Text]  
• Bezdicek, P., Worgall, S., Kovesdi, I., Kim, M.-K., Park, J.-G., Vincent, T., Leopold, P. L., Schreiber, A. D., Crystal, R. G. (1999). Enhanced Liver Uptake of Opsonized Red Blood Cells After In Vivo Transfer of Fcgamma RIIA cDNA to the Liver. Blood 94: 3448-3455 [Abstract] [Full Text]  
• Le Meur, Y., Lorgeot, V., Aldigier, J.-C., Wijdenes, J., Leroux-Robert, C., Praloran, V. (1999). Whole blood production of monocytic cytokines (IL-1{beta}, IL-6, TNF-{alpha}, sIL-6R, IL-1Ra) in haemodialysed patients. Nephrol Dial Transplant 14: 2420-2426 [Abstract] [Full Text]  
• Szycher, M. (1999). End-Stage Renal Disease (ESRD) and Vascular Access Grafting: A Critical Review. J Biomater Appl 13: 297-350 [Abstract]  
• Ifudu, O. (1998). Care of Patients Undergoing Hemodialysis. NEJM 339: 1054-1062 [Full Text]  
• Prabhakar, S. S., Zeballos, G. A., Montoya-Zavala, M., Leonard, C. (1997). Urea inhibits inducible nitric oxide synthase in macrophage cell line. Am. J. Physiol. Cell Physiol. 273: C1882-C1888 [Abstract] [Full Text]  
• Schiff, D. E., Rae, J., Martin, T. R., Davis, B. H., Curnutte, J. T. (1997). Increased Phagocyte Fcgamma RI Expression and Improved Fcgamma -Receptor-Mediated Phagocytosis After In Vivo Recombinant Human Interferon-gamma Treatment of Normal Human Subjects. Blood 90: 3187-3194 [Abstract] [Full Text]  
• Gomez, F., Ruiz, P., Schreiber, A. D. (1994). Impaired Function of Macrophage Fc{gamma} Receptors and Bacterial Infection in Alcoholic Cirrhosis. NEJM 331: 1122-1128 [Abstract] [Full Text]